Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Short term Debt (2019 - 2026)

Updated

Oncotelic Therapeutics (OTLC) reported Short term Debt of $12.04 million for Q2 2026.

Analysis

Oncotelic Therapeutics (OTLC) Short term Debt (2019 - 2026) Analysis & Trends

At the end of FY2025, Oncotelic Therapeutics posted Short term Debt of $12.25 million.

  • Short term Debt has a five-year compound annual growth rate of 43.7% (FY2020 to FY2025).
  • By year, Short term Debt came in at $11.26 million in FY2022 (+176.6%) and $4.07 million in FY2021 (+103.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Short term Debt since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.04 Mn
Dec 31, 2025 12.25 Mn
Sep 30, 2023 11.48 Mn
Jun 30, 2023 12.13 Mn
Dec 31, 2022 11.26 Mn
Dec 31, 2021 5.74 Mn
Sep 30, 2021 4.08 Mn
Jun 30, 2021 3.95 Mn
Mar 31, 2021 3.24 Mn
Dec 31, 2020 3.34 Mn
Sep 30, 2020 1.02 Mn
Jun 30, 2020 1.22 Mn
Mar 31, 2020 1.10 Mn
Dec 31, 2019 944,450.00
Sep 30, 2019 450,287.00
Jun 30, 2019 227,925.00
API Access

Oncotelic Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=OTLC&period=max&api_key=YOUR_API_KEY